• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Sanofi says it's back to the drawing board on mRNA flu vaccines

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 29, 2023 at 11:22: AM
via Sanofi (SASY.PA) said that trials show the currently available mRNA technology behind the most successful COVID-19 shots will not be effective against influenza and it is already working on a next generation of shots.

article source
 




Top Bottom
Back
Quote